Annual EPS
-$3.17
+$3.92+55.29%
December 31, 2023
Summary
- As of February 12, 2025, CKPT annual earnings per share is -$3.17, with the most recent change of +$3.92 (+55.29%) on December 31, 2023.
- During the last 3 years, CKPT annual EPS has risen by +$0.93 (+22.68%).
- CKPT annual EPS is now at all-time high.
Performance
CKPT EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.23
-$0.05-27.78%
September 30, 2024
Summary
- As of February 12, 2025, CKPT quarterly earnings per share is -$0.23, with the most recent change of -$0.05 (-27.78%) on September 30, 2024.
- Over the past year, CKPT quarterly EPS has increased by +$0.06 (+20.69%).
- CKPT quarterly EPS is now -27.78% below its all-time high of -$0.18, reached on June 30, 2024.
Performance
CKPT Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$1.84
+$0.06+3.16%
September 30, 2024
Summary
- As of February 12, 2025, CKPT TTM earnings per share is -$1.84, with the most recent change of +$0.06 (+3.16%) on September 30, 2024.
- Over the past year, CKPT TTM EPS has increased by +$2.70 (+59.47%).
- CKPT TTM EPS is now -19.89% below its all-time high of -$1.53, reached on September 30, 2015.
Performance
CKPT TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
CKPT EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.3% | +20.7% | +59.5% |
| 3 y3 years | +22.7% | +80.8% | +78.7% |
| 5 y5 years | +75.0% | +61.7% | +68.3% |
CKPT EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +57.5% | -27.8% | +94.0% | at high | +79.2% |
| 5 y | 5-year | at high | +57.5% | -27.8% | +94.0% | at high | +79.2% |
| alltime | all time | at high | +75.0% | -27.8% | +94.0% | -19.9% | +85.6% |
Checkpoint Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.23(+27.8%) | -$1.84(-3.2%) |
| Jun 2024 | - | -$0.18(-45.5%) | -$1.90(-31.4%) |
| Mar 2024 | - | -$0.33(-70.0%) | -$2.77(-16.8%) |
| Dec 2023 | -$3.17(-55.3%) | -$1.10(+279.3%) | -$3.33(-26.7%) |
| Sep 2023 | - | -$0.29(-72.4%) | -$4.54(-16.7%) |
| Jun 2023 | - | -$1.05(+18.0%) | -$5.45(-9.5%) |
| Mar 2023 | - | -$0.89(-61.5%) | -$6.02(-15.3%) |
| Dec 2022 | -$7.09(-4.8%) | -$2.31(+92.5%) | -$7.11(-17.8%) |
| Sep 2022 | - | -$1.20(-25.9%) | -$8.65(-2.3%) |
| Jun 2022 | - | -$1.62(-18.2%) | -$8.85(+5.0%) |
| Mar 2022 | - | -$1.98(-48.6%) | -$8.43(+14.7%) |
| Dec 2021 | -$7.45(+81.7%) | -$3.85(+175.0%) | -$7.35(+41.3%) |
| Sep 2021 | - | -$1.40(+16.7%) | -$5.20(+10.6%) |
| Jun 2021 | - | -$1.20(+33.3%) | -$4.70(+6.8%) |
| Mar 2021 | - | -$0.90(-47.1%) | -$4.40(+7.3%) |
| Dec 2020 | -$4.10 | -$1.70(+88.9%) | -$4.10(-10.9%) |
| Sep 2020 | - | -$0.90(0.0%) | -$4.60(-11.5%) |
| Jun 2020 | - | -$0.90(+50.0%) | -$5.20(-10.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$0.60(-72.7%) | -$5.80(-17.1%) |
| Dec 2019 | -$7.00(-44.9%) | -$2.20(+46.7%) | -$7.00(-18.6%) |
| Sep 2019 | - | -$1.50(0.0%) | -$8.60(-16.5%) |
| Jun 2019 | - | -$1.50(-16.7%) | -$10.30(-7.2%) |
| Mar 2019 | - | -$1.80(-52.6%) | -$11.10(-13.3%) |
| Dec 2018 | -$12.70(+27.0%) | -$3.80(+18.8%) | -$12.80(+10.3%) |
| Sep 2018 | - | -$3.20(+39.1%) | -$11.60(+5.5%) |
| Jun 2018 | - | -$2.30(-34.3%) | -$11.00(-4.3%) |
| Mar 2018 | - | -$3.50(+34.6%) | -$11.50(+15.0%) |
| Dec 2017 | -$10.00(-3.8%) | -$2.60(0.0%) | -$10.00(-7.5%) |
| Sep 2017 | - | -$2.60(-7.1%) | -$10.81(+4.9%) |
| Jun 2017 | - | -$2.80(+40.0%) | -$10.31(+6.0%) |
| Mar 2017 | - | -$2.00(-41.3%) | -$9.72(+5.7%) |
| Dec 2016 | -$10.40(+82.9%) | -$3.41(+62.3%) | -$9.20(+1.2%) |
| Sep 2016 | - | -$2.10(-5.1%) | -$9.08(+6.6%) |
| Jun 2016 | - | -$2.21(+49.9%) | -$8.52(+35.1%) |
| Mar 2016 | - | -$1.48(-55.2%) | -$6.31(+30.5%) |
| Dec 2015 | -$5.69 | -$3.30(+114.8%) | -$4.83(+214.8%) |
| Sep 2015 | - | -$1.53 | -$1.53 |
FAQ
- What is Checkpoint Therapeutics annual earnings per share?
- What is the all time high annual EPS for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics annual EPS year-on-year change?
- What is Checkpoint Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics quarterly EPS year-on-year change?
- What is Checkpoint Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics TTM EPS year-on-year change?
What is Checkpoint Therapeutics annual earnings per share?
The current annual EPS of CKPT is -$3.17
What is the all time high annual EPS for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high annual earnings per share is -$3.17
What is Checkpoint Therapeutics annual EPS year-on-year change?
Over the past year, CKPT annual earnings per share has changed by +$3.92 (+55.29%)
What is Checkpoint Therapeutics quarterly earnings per share?
The current quarterly EPS of CKPT is -$0.23
What is the all time high quarterly EPS for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high quarterly earnings per share is -$0.18
What is Checkpoint Therapeutics quarterly EPS year-on-year change?
Over the past year, CKPT quarterly earnings per share has changed by +$0.06 (+20.69%)
What is Checkpoint Therapeutics TTM earnings per share?
The current TTM EPS of CKPT is -$1.84
What is the all time high TTM EPS for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high TTM earnings per share is -$1.53
What is Checkpoint Therapeutics TTM EPS year-on-year change?
Over the past year, CKPT TTM earnings per share has changed by +$2.70 (+59.47%)